ISTA Pharmaceuticals' IPO

ISTA Pharmaceuticals raised a round of funding on August 22, 2000. Investors include Public.

ISTA Pharmaceuticals develops ophthalmic pharmaceuticals. In March 2012, ISTA Pharmaceuticals was acquired by Bausch & Lomb. The valuation of ISTA Pharmaceuticals was $500 million.…

Articles about ISTA Pharmaceuticals' IPO: